Teva dispenses $2.6 million to resolve ERISA claims | Pensions & Investments
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva Reports Earnings Tomorrow. Here's What to Expect. | Barron's
Jewish Values Investors JLens Target Israeli Company
Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceuticals Portfolio Investments, Teva Pharmaceuticals Funds, Teva Pharmaceuticals Exits
Teva Selling $3.5 Billion of Junk Bonds to Refinance Debt - Bloomberg
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva Reports Second Quarter 2022 Financial Results | Business Wire
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Here's Why Teva Shares are Trending Higher Today - TipRanks.com
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceutical Industries — 9 Portfolio companies, 10 Investments, Team — Unicorn Nest
Buy Teva Pharmaceuticals amid positive news, Bernstein says
